A Randomized, Double-Blind, Placebo-Controlled Trial Of AC-201 In Subjects With Gout Initiating Urate-Lowering Therapy
Phase of Trial: Phase II
Latest Information Update: 24 May 2018
At a glance
- Drugs Diacerein (Primary) ; Antigouts
- Indications Gout
- Focus Proof of concept; Therapeutic Use
- Sponsors TWi Biotechnology
- 30 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jun 2013 The results of this trial will be available before the end of 2014, according to a TWi Biotechnology media release.
- 17 Jun 2013 Patient enrollment has been completed ahead of schedule, acccording to a TWi Biotechnology media release.